Altimmune (ALT) Restructuring Costs (2015)
Altimmune (ALT) recorded Restructuring Costs of $26,886 in Q4 2015, down 93.6% from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) Restructuring Costs (2015) Analysis & Trends
For FY2015, Altimmune reported Restructuring Costs of $2.55 million.
- Per Business Quant, the preceding three quarters came in at $422,482 (Q3 2015), $35,982 (Q2 2015) and $2.06 million (Q1 2015).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.42 Bn | 1,106.00 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.98 Bn | 536.51 Bn | 17.26 Bn |
| 3 | AbbVie | 502.80 Bn | 475.92 Bn | 12.70 Bn |
| 4 | Merck | 368.67 Bn | 323.05 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.36 Bn | 262.35 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.17 Bn | 234.85 Bn | 12.86 Bn |
| 7 | Amgen | 237.18 Bn | 192.58 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.11 Bn | 165.31 Bn | 6.22 Bn |
| 9 | Pfizer | 169.83 Bn | 116.48 Bn | 10.94 Bn |
| 10 | Altimmune | 413.54 Mn | -728.68 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | 26,886.00 |
| Sep 30, 2015 | 422,482.00 |
| Jun 30, 2015 | 35,982.00 |
| Mar 31, 2015 | 2.06 Mn |
API Access
Altimmune Restructuring Costs API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=restructuring-costs&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "restructuring-costs", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=restructuring-costs&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();